As mentioned above, after receiving anti-inflammatory treatment (the TNF antagonist infliximab), BD patients exhibited reduced peripheral inflammation levels, while whole-brain cortical thickness tended to increase (Mansur et al. 2020). Here, TNF is linked to Behcet disease.